Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I'd Like to See a PP at $.25 with Warrants for 1 yr at $.50

<< Previous

Bullboard Posts

Next >>

Comment by riverrrowon Jun 11, 2024 1:31pm

182 Views

Post# 36083105

RE:RE:RE:RE:RE:RE:I'd Like to See a PP at $.25 with Warrants for 1 yr at $.50

By May 30, 2023 TLT reported 39 patients had reached 450 days or 15 months. By May 30 of this year these patients will have reached 27 months. We're all looking forward to finding out how many have had follow ups for at least the 24 month mark and what their CR is. Good luck to both the patients and TLT shareholders.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments